Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Neurocrit Care. 2020 Sep 30;34(3):889–898. doi: 10.1007/s12028-020-01113-z

Table 1.

Baseline characteristics of control and SAH patients stratified by outcome.

Control SAH
All p-value Good Outcome (GOS 4–5) Poor Outcome (GOS 1–3) p-value

Participants, n 9 18 - 10 8 -

Age, mean (SD) 43.5 (14.6) 50.4 (9.9) 0.106 48.4 (7.5) 52.8 (12.3) 0.360

Female Sex, n (%) 5 (55.6) 11 (61.1) >0.999 6 (60.0) 5 (62.5) >0.999

Anterior Aneurysm Location, n (%) -- 14 (77.8) -- 7 (70.0) 7 (87.5) 0.588

Modified Fisher Scale, median (IQR) -- 3 (3–4) -- 3 (3–4) 4 (3–4) 0.475

Hunt-Hess Score, median (IQR) -- 3 (2–5) -- 2.5 (2–3) 3 (2–5) 0.146

Glasgow Coma Scale, median (IQR) -- 14 (6.75–15) -- 14.5 (14–15) 10 (4–14) 0.034

Aneurysm Treatment, n (%)
Surgical Clipping -- 10 (55.6) -- 5 (50.0) 5 (62.5) 0.664
Endovascular Coiling 8 (44.4) 5 (50.0) 3 (37.5)

Angiographic Vasospasm, n (%) -- 12 (66.7) -- 6 (60.0) 5 (62.5) 0.638

Delayed Neurologic Deterioration, n (%) -- 9 (50.0) -- 3 (30.0) 6 (75.0) 0.153

SAH: Subarachnoid Hemorrhage, GOS: Glasgow Outcome Score, SD: Standard Deviation, IQR: Interquartile Range